Clinical Trials Browser

Unknown × ofatumumab × Clear all

NCT03280160 2022-09-16

Protocol GELLC-7: Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01678430 2012-10-15

RIAltO

Phase 3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT01221103 2011-09-13

Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL)

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell